Rapport Therapeutics, Inc. · NASDAQ:RAPP
Sofinnova Venture Partners XI, L.P. ("SVP XI") reported a 4.00% stake in Rapport Therapeutics, Inc. (Schedule 13D/A)
Event Sep 11, 2025 · Filed Sep 18, 2025
Sofinnova Venture Partners XI, L.P. ("SVP XI") reported a 4.00% stake in Rapport Therapeutics, Inc., 1,863,327 shares, with active intent on Sep 11, 2025. Filed Sep 18, 2025 (Schedule 13D/A).
- Stake
- 4.00%
- Shares
- 1,863,327
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sofinnova Venture Partners XI, L.P. ("SVP XI") | 4.00% | 1,863,327 |
| Sofinnova Management XI, L.P. ("SM XI LP") | 4.00% | 1,863,327 |
| Sofinnova Management XI, L.L.C. ("SM XI LLC") | 4.00% | 1,863,327 |
| Dr. James I. Healy ("Healy") | 4.20% | 1,947,579 |
| Dr. Maha Katabi ("Katabi") | 4.00% | 1,863,327 |
Source
Related
- Rapport Therapeutics, Inc.
- Sofinnova Venture Partners XI, L.P. ("SVP XI")
- Rapport Therapeutics, Inc. shareholders
- Form 4 · Maraganore John · Oct 22, 2026
- Form 4 · Silva Paul M · Oct 22, 2026
- Form 4 · Young Wendy B. · Oct 22, 2026
- Form 4 · Paul Steven M · Oct 22, 2026
- Form 4 · Ignelzi Troy A. · Oct 21, 2026